Shady Ibrahim

Shady Ibrahim is the Executive Medical Director at Eli Lilly and Company, where they lead diverse roles within medical affairs, focusing on therapy area management and developing medical capabilities. With extensive experience in Multiple Sclerosis, Transplantation, Dermatology, Rheumatology, rare diseases, respiratory health, and Heart Failure in the Middle East, Shady excels at identifying and building long-term strategic partnerships with thought leaders and key decision-makers. They previously held several significant positions, including Senior Medical Officer at Oman Insurance Company PSC and various roles at Novartis, contributing to their well-rounded expertise. Shady is pursuing a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the Faculty of Medicine at Cairo University.